Library / Laws / 119th Congress / House Bills / H.R. 10887

H.R. 10887

To prohibit brand name drug manufacturers from compensating generic drug manufacturers to delay the entry of a generic drug into the market, to prohibit biological product manufacturers from compensating biosimilar and interchangeable product manufacturers to delay entry of biosimilar and interchangeable products, and for other purposes.

House · 1 version on the shelf